1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. MYRIAD GENETICS, INC.
Myriad Genetics, Inc. XNAS: MYGN
6.61 -0.18 (-2.65%)
1.3M
XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Myriad Genetics, Inc. is on 10 Sep 2025 for the purpose of The Morgan Stanley Annual Global Healthcare Conference See details

Myriad Genetics, Inc. - MYGN - stock price prediction, stock price target, analyst ratings from 14 analysts

Myriad Genetics, Inc. has a share price target of US$ 7, revenue growth forecast of -1.8%, and profit growth estimate of -189.3% for FY25, based on top 14 analyst calls.